Despite the high in vitro efficacy of photodynamic therapeutics, lack of tumor targeting
significantly reduces their in vivo efficacy and thus limits their clinical use …

Photodynamic therapy (PDT) is a promising approach for the treatment of superficially
localized tumors. A limitation, however, is the lack of selectivity of the photosensitizers, which …

Photodynamic therapy (PDT) combines a photosensitizer (PS) with the physical energy of
non-ionizing light to trigger cell death pathways. PDT has potential as a therapeutic modality …

Targeting photosensitizers to cancer cells by conjugating them with specific antibodies, able
to recognize and bind to tumor-associated antigens, is today one of the most attractive …

Photodynamic therapy (PDT) is a clinically approved procedure that can exert a curative
action against malignant cells. The treatment implies the administration of a photoactive …

Photosensitizer immunoconjugates (PICs) offer improved photosensitizer delivery specificity
and could broaden the applicability of photodynamic therapy (PDT) in the treatment of …

Photodynamic therapy (PDT) is a clinically approved treatment modality for cancer and
superficial lesions. It harnesses the photochemical reaction between the light‐sensitizing …

Current photodynamic therapy (PDT) of cancer is limited by inefficiencies involved in
specifically targeting photosensitizers to tumors. Although antibodies are being explored as …

Coupling of photosensitizers to tumor‐selective monoclonal antibodies (MAbs) is an
attractive option for improving the selectivity of photodynamic therapy (PDT). For this …

Photodynamic therapy (PDT) has been used as an alternative or as a complement of
conventional approaches for cancer treatment. In PDT, the reactive oxygen species (ROS) …